Conatus Pharmaceuticals Inc. (Nasdaq: CNAT) priced its public offering of 5.2 million common shares at the discounted price of $5.50 per share sending the stock price tumbling $1.51 to close at $5.51.
Conatus Pharmaceuticals prices offering at discount
May 11, 2017 at 19:01 PM EDT
